Teda Biomedical (08189) released the interim performance announcement for the first half of 2024, and the group achieved a comprehensive turnover of RMB 2 billion....
According to the announcement of Teda Biomedical (08189) on the half-year performance in 2024, the group achieved a comprehensive turnover of RMB 0.212 billion, an increase of 16.24% year-on-year; the equity owners suffered a loss of RMB 4.1232 million, a decrease of 63.35% year-on-year; the loss per share was RMB 0.218.
